Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy

Sponsor
Ciusss de L'Est de l'Île de Montréal (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05967936
Collaborator
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal (Other)
242
1
2
15
16.1

Study Details

Study Description

Brief Summary

Hysteroscopy is a minimally invasive, diagnostic and therapeutic gynecological surgical technique and the gold standard in the study of the uterine cavity. Thanks to the decrease in the diameter of hysteroscopes and to the vaginoscopic approach, anesthesia is no longer necessary in diagnostic hysteroscopy. Nevertheless, in operative hysteroscopy, given the instrumentalization and the need of cervical dilation, the use of local anesthesia, with or without sedation, is recommended. The different alternatives described in the literature are the following:

  1. Cervical/ intracervical block: injection of local anesthetic into the four quadrants of the cervix.

  2. Paracervical block: injection of local anesthetic in the cervicovaginal junction at 5 and 7 o'clock positions.

  3. Transcervical (uterine) anesthesia: instillation of a local anesthetic agent via catheter through the cervix and into the uterine cavity.

  4. Topical cervical anesthesia: application of local anesthetic in gel or spray to the cervix.

To assess the best anesthetic pathway to decrease pain during outpatient hysteroscopy, the investigators will perform a prospective multicentric study that compare two types of local anesthesia in outpatient procedural hysteroscopy: paracervical block, that is the actual gold-standard, and transcervical instillation.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bupivacaine Injection
N/A

Detailed Description

To assess the best anesthetic pathway to decrease pain during outpatient hysteroscopy, the investigators will perform a multicentric prospective randomized trial, single-blinded, that compares two types of local anesthesia in outpatient procedural hysteroscopy: paracervical block, that is the actual gold-standard, and transcervical instillation.

The population studied will consist in adult women with indication of an outpatient surgical hysteroscopy (myomectomy or polypectomy). Every one of them will be invited to participate the day of their procedure. In the outpatient hysteroscopy clinic, the investigators will verify inclusion and exclusion criteria, explain the objectives of the study, collect data and obtain the patient's consent.

The sample size is 242 patients (121 in each group). The study will be performed in two different centers:

  • Integrated University Health Center and Social Services of the East of the Island of Montreal

  • Integrated University Health Center and social services of the South Center of the Island of Montreal

Right before each procedure the patients will be randomized through anonymous and alternized enveloppes that will be distributed in each center, to either receive paracervical or transcervical anesthesia before hysteroscopy.

Each patient will receive a pre-established dose of sedative before the procedure, according to their weight: Fentanyl 0,5 mcg/kg IV and Midazolam 0,02 mg/kg. The subsequent doses will be noted.

Under sedation, with the patient in lithotomy position, a medium size speculum will be inserted. The vagina will be disinfected with chlorhexidine and the anterior lip of the cervix will be gripped with a Pozzi forceps.

According to previous randomization, each patient will receive one of the following alternatives of local anesthesia:

  • Group A: Paracervical 10cc Bupivacaine 1%, without epinephrine, at 0.5-1 cm depth of the cervicovaginal junction at 5 and 7 o'clock positions (20cc in total).

  • Group B: Transcervical (uterine) 10cc Bupivacaine 1% through the endocervix using an 17-Gauge epidural catheter

During the procedure (T1), the nurse will be in charge to fill the scale (to avoid bias). The patients will be given a Visual Analogue Scale (VAS) to fill 15 minutes after the procedure (before discharge), to assess pain.

For each group the investigators will calculate the average rate of pain according to the Visual Analogue Scale during and immediately after the procedure (15 minutes). The investigators will subdivide each group into pre and postmenopausal women and into nulliparous and parous women and compare their Visual Analogue Scale as well.

Statistical analysis will be performed to compare results.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
242 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Multicentric, prospective, randomized trial, single-blinded, where eligible patients will be randomized to either receive paracervical or transcervical anesthesia before outpatient surgical hysteroscopyMulticentric, prospective, randomized trial, single-blinded, where eligible patients will be randomized to either receive paracervical or transcervical anesthesia before outpatient surgical hysteroscopy
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
A Prospective Randomized Study Comparing Different Types of Local Anesthesia in Outpatient Procedural Hysteroscopy
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Paracervical block

10cc Bupivacaine 1% at 0.5-1 cm depth of the cervicovaginal junction at 5 and 7 o'clock positions (20cc in total).

Drug: Bupivacaine Injection
evaluation of pain by using two different types of local anesthesia
Other Names:
  • evaluation of pain by using two different types of local anesthesia
  • Experimental: Transcervical block

    10cc Bupivacaine 1% through the endocervix using an 17-gauge epidural catheter

    Drug: Bupivacaine Injection
    evaluation of pain by using two different types of local anesthesia
    Other Names:
  • evaluation of pain by using two different types of local anesthesia
  • Outcome Measures

    Primary Outcome Measures

    1. To assess the best anesthetic pathway to decrease pain during outpatient hysteroscopy [during hysteroscopy]

      comparing 10 point visual analogue scale (from 0 to 10 points) between two groups of patients recieving Bupivacaine administrated through a paracervical block versus a transcervical block

    2. To assess the best anesthetic pathway to decrease pain during outpatient hysteroscopy [15 minutes post hysteroscopy]

      comparing 10 point visual analogue scale (from 0 to 10 points) between two groups of patients recieving Bupivacaine administrated through a paracervical block versus a transcervical block

    Secondary Outcome Measures

    1. Compare the pain experience based on the visual analogue scale between pre and post-menopausal patients [during hysteroscopy]

      Compare the pain experience based on the 10 point visual analogue scale (from 0 to 10 points) between pre and post-menopausal patients

    2. Compare the pain experience based on the visual analogue scale between pre and post-menopausal patients [15 minutes post hysteroscopy]

      Compare the pain experience based on the 10 point visual analogue scale (from 0 to 10 points) between pre and post-menopausal patients

    3. Compare the pain experience based on the visual analogue scale between nulliparous and parous patients [during hysteroscopy]

      Compare the pain experience based on the 10 point visual analogue scale (from 0 to 10 points) between nulliparous and parous patients

    4. Compare the pain experience based on the visual analogue scale between nulliparous and parous patients [15 minutes post hysteroscopy]

      Compare the pain experience based on the 10 point visual analogue scale (from 0 to 10 points) between nulliparous and parous patients

    5. To evaluate the need for an extra intravenous sedative dose. [during hysteroscopy]

      Number of patients who demand an extra dose of sedative during hysteroscopy

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female patients

    • 18 years of age or older

    • Indication of outpatient surgical hysteroscopy for polypectomy and myomectomy

    Exclusion Criteria:
    • Women under 18 years old

    • Unable to understand how to score a visual analog scale pain score

    • Hysteroscopy contraindication

    • Patients with medical history or current status that makes outpatient procedure usafe

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CIUSSS de l'Est de l'Île de Montréal Montréal-Est Quebec Canada H1T 2M4

    Sponsors and Collaborators

    • Ciusss de L'Est de l'Île de Montréal
    • Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

    Investigators

    • Study Director: Mélissa Roy, MD, OB-GYN

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Ciusss de L'Est de l'Île de Montréal
    ClinicalTrials.gov Identifier:
    NCT05967936
    Other Study ID Numbers:
    • MP-12-2023-3238
    First Posted:
    Aug 1, 2023
    Last Update Posted:
    Aug 1, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Ciusss de L'Est de l'Île de Montréal
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2023